文献速递妇科生殖医学

多囊卵巢综合征的糖尿病发病率和患病率及疾病成本分析:一项贝叶斯建模研究

Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
PubMed 文献 · Hum Reprod · 2018-01-01

该建模研究利用2004至2014年英国初级保健数据库的14135名多囊卵巢综合征(PCOS)或提示PCOS症状的女性数据,模拟PCOS人群25年动态变化。

要点

  • PCOS女性2型糖尿病发病率为每1000人年3-33例,患病率为26.5%(95%区间:25.4-27.8%)。
  • 从可能PCOS到确诊PCOS的峰值转化率为每1000人年121例。

核心结论

  • 作者认为,大量有PCOS提示症状的女性从未获得确诊却可能快速进展为糖尿病,将其纳入国家筛查项目可能具有成本效益。

研究设计与样本

  • 建模研究,使用2004至2014年英国初级保健数据库的个体患者数据及文献汇总数据获取PCOS疾病进展转化率。
  • 采用模拟方法对PCOS人群动态进行25年随访建模。
  • 从初级保健数据库选取14135名PCOS或提示PCOS症状的女性,估计确诊PCOS和2型糖尿病的发病率。
  • 模拟包含整个PCOS人群(规模根据英国人口普查数据估计)的虚拟队列,从医疗保健视角进行经济和效用分析。

主要发现

  • 从可能PCOS到确诊PCOS的峰值转化率为每1000人年121例。
  • 2型糖尿病最高发病率为每1000人年33例。
  • 25年随访期间PCOS人群糖尿病估计患病率为26.5%(95%区间:25.4-27.8%)。

临床怎么用

  • 作者认为,大量有PCOS提示症状的女性从未获得确诊却可能快速进展为糖尿病,这显著降低个体患者生活质量并给医疗提供者带来高成本。
  • 作者认为,由于PCOS女性糖尿病风险与糖尿病高危人群相似,将其纳入国家筛查项目可能具有成本效益。

局限性

  • 由于缺乏数据,无法进行包含PCOS所有相关合并症医疗成本的完整经济学评价。
  • 模型对现实世界情况的简化可能是一个问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the incidence/prevalence of type 2 diabetes in women with polycystic ovary syndrome (PCOS) and the economic burden associated with PCOS in the UK? SUMMARY ANSWER: The incidence and prevalence of type 2 diabetes in women with PCOS are 3-33 per 1000 person years and 26.5%, respectively, with an associated annual healthcare burden of at least £237 million in the UK. WHAT IS KNOWN ALREADY: Although observational studies have been designed to assess the incidence of diabetes in women with PCOS, these have been open to criticism because of short periods of follow-up, small sample sizes or invalidated diagnosis of PCOS. Only one study has estimated the healthcare-related economic burden of PCOS, reporting a cost of $4.36 billion per year in the USA. STUDY DESIGN, SIZE, DURATION: This was a modelling study using individual patient data from a UK primary care database between 2004 and 2014 and aggregate data from the literature to obtain conversion rates through disease progression of PCOS. A simulation approach was applied to model the population dynamics of PCOS over a follow-up period of 25 years. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 14 135 women with PCOS or symptoms indicative of PCOS were selected from the primary care database to estimate the incidence of confirmed diagnosis of PCOS and diagnosis of type 2 diabetes. A 'virtual' cohort including the entire PCOS population (size estimated from the UK census data) was simulated to model the population dynamics of PCOS. The economic and utility analyses were further conducted from a healthcare perspective. MAIN RESULTS AND THE ROLE OF CHANCE: The peak conversion rate from possible to diagnosed PCOS was 121 per 1000 person-year (PY). The maximal incidence of type 2 diabetes was 33 per 1000 PY. The estimated prevalence of diabetes in the PCOS population was 26.5% (95% interval: 25.4-27.8%) during a 25-year follow-up. The annual healthcare burden of PCOS based on our conservative estimate is at least £237 million for the follow-up period examined. LIMITATIONS, REASONS FOR CAUTION: Due to lack of data, a full economic evaluation including healthcare costs of all the comorbidities associated with PCOS was not possible. Simplification of the real-world situation represented by the model may be a concern. WIDER IMPLICATIONS OF THE FINDINGS: This study suggests that a large number of women with symptoms indicative of PCOS never receive a definitive diagnosis yet can suffer from a rapid conversion to diabetes. This significantly reduces the quality of life for individual patients and incurs high costs for healthcare providers. As the risk of diabetes in women with PCOS is similar to that seen in populations at high risks of diabetes, it is possible that including them in national screening programmes may be cost effective. STUDY FUNDING/COMPETING INTEREST(S): There was no funding for the current study. There are no conflicts of interest. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ding T, Hardiman PJ, Petersen I, et al. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study. Hum Reprod. 2018. PMID: 29684121. doi:10.1093/humrep/dey093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。